Treasury Wine Estates — Is This a Buying Opportunity or a Falling Knife?
First-half earnings fell nearly 40% and the company booked a $751 million write-down. With the stock near multi-year lows, retail investors are asking whether the pain is priced in — or whether there is more to come.
Treasury Wine Estates (ASX: TWE) has delivered one of its most difficult half-year results in recent memory. Earnings before interest and tax (EBITS) came in at $236.4 million for the six months to 31 December 2025 — down 39.6% year-on-year. The result technically met management's own guidance range of $225–$235 million, but that guidance had already been sharply downgraded in December. Beneath the headline number, the company booked a statutory net loss of $649.4 million, driven by a $751 million non-cash write-down of its US brand assets. For retail investors holding TWE shares or weighing a first entry, the question is simple: is this the bottom, or is there further pain ahead? What Went Wrong Three forces combined to produce these results. First, China: Penfolds — Treasury's premium flagship — saw earnings fall approximately 20% as demand remained sluggish and offline retail prices softened. The post-tariff recovery that investors had hoped for has been slower and shallower than expected. Second, the Americas: Treasury Americas earnings collapsed roughly 67% following the messy termination of its relationship with Californian distributor RNDC. The company has now confirmed a US$65 million cash settlement payment in the second half, plus an estimated $100 million to repurchase inventory sitting in the pipeline — stock it will likely sell at zero profit margin. Third, the broader US wine market is structurally weak, with consumer preference shifting away from wine and toward spirits and ready-to-drink alternatives. The Case for Buying: Bad News May Be Priced In For contrarian investors, there are reasons to think the worst may be behind the company. The $751 million write-down, while painful, is non-cash — it does not affect Treasury's ability to operate or generate revenue. It is an accounting acknowledgement of a problem the market had already identified. The RNDC settlement, similarly, has now been quantified, removing a major source of uncertainty that had been hanging over the stock. Management's new "TWE Ascent" transformation program is targeting $100 million in annual cost savings, and while benefits are not expected until FY27, it signals that the new leadership team is moving decisively. Penfolds remains one of the strongest luxury wine brands in the world, and any meaningful recovery in Chinese consumer sentiment could materially re-rate the stock. If you believe China recovers over a 12–24 month horizon and management executes on its cost program, the current price could look attractive in hindsight. The stock is trading well below where analysts set fair value as recently as 2024. The Case for Waiting: Structural Risks Remain Real The more cautious view — and currently the dominant one among professional analysts — is that the problems facing Treasury are not simply cyclical. The US wine category is in structural decline, and Treasury's Americas division is caught in the middle of a multi-year inventory unwind with no clear earnings recovery on the horizon. Gearing sits at approximately 2.5 times, above management's own target of 1.5–2.0 times, meaning the balance sheet has little room to absorb further shocks. UBS, Citi, and Ord Minnett all maintain Sell or equivalent ratings, with target prices clustering between $4.75 and $5.25. The China recovery, while possible, is far from guaranteed. Lower offline retail pricing for Penfolds suggests distributors are discounting to move stock — which can erode brand perception over time. For a company whose premium positioning is its core competitive advantage, sustained price discounting is a strategic risk that goes beyond the current earnings cycle. The Investor Verdict: Wait for Clearer Signals On balance, the risk-reward for retail investors currently skews toward patience over action. The bad news is becoming better understood, which is a necessary precondition for a recovery — but understanding the bad news is not the same as having left it behind. The Americas inventory unwind, the RNDC cash outflows, and the uncertain China trajectory all point to a difficult second half before any genuine improvement takes hold. If you already hold TWE shares, the case for panic-selling at current prices is weak — much of the damage is done and the write-downs are non-cash. But for investors considering a fresh entry, the smarter move may be to wait for two things: evidence that Penfolds pricing in China is stabilising, and early signs that the "TWE Ascent" cost program is delivering real savings. Chasing a recovery before those signals emerge carries meaningful downside risk.
Read on MPC Markets Mosaic
